Women with large (≥3 cm) and locally advanced breast cancers (T3, 4, N1, 2, M0) receiving neoadjuvant chemotherapy (NAC: cyclophosphamide, doxorubicin, docetaxel): addition of capecitabine improves 4-year disease-free survival

PURPOSE: To determine whether capecitabine (X), combined with docetaxel (T) following doxorubicin (A) and cyclophosphamide (C), enhanced the pathological complete response (pCR) in the breast and axillary lymph nodes (ALNs) of women with large or locally advanced breast cancers (LLABCs) improving ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Eremin, Jennifer, Cowley, Ged, Walker, Leslie G, Murray, Elisabeth, Stovickova, Monika, Eremin, Oleg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429427/
https://www.ncbi.nlm.nih.gov/pubmed/25995984
http://dx.doi.org/10.1186/2193-1801-4-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429427/
https://www.ncbi.nlm.nih.gov/pubmed/25995984
http://dx.doi.org/10.1186/2193-1801-4-9

Ejemplares similares